Related Experiment Video

Updated: Jul 11, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Higher Thrombelastograph platelet reactivity in cardiac surgery patients than in blood donors

Louise Bochsen1, Allan Bybeck Nielsen, Daniel A Steinbrüchel

  • 1Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. louise.bochsen@rh.regionh.dk

Scandinavian Cardiovascular Journal : SCJ
|September 14, 2007
PubMed

Insights

Cardiac surgery patients exhibit higher platelet reactivity and ADP response compared to healthy donors, indicating an increased risk for ischemic events. This finding highlights potential implications for patient management and risk stratification.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Surgical Research

Background:

  • Platelet reactivity assessed by Thrombelastograph (TEG) is a known predictor of ischemic events post-percutaneous coronary intervention (PCI).
  • Understanding platelet behavior in cardiac surgery is crucial for managing perioperative risks.

Purpose of the Study:

  • To investigate platelet hyperreactivity in patients undergoing coronary artery bypass grafting (CABG) surgery.
  • To assess the variability in platelet reactivity, specifically the response to adenosine diphosphate (ADP), in CABG patients compared to healthy blood donors.

Main Methods:

  • Preoperative blood samples were collected from 22 CABG patients and 43 healthy blood donors.
  • The TEG Platelet Mapping assay was utilized to analyze maximal platelet reactivity (MAThrombin) and platelet reactivity response to ADP stimulation (MAADP).

Main Results:

  • CABG patients demonstrated significantly higher MAThrombin (p=0.001) and MAADP (p<0.0001) compared to blood donors.
  • A greater proportion of CABG patients (27.2%) had elevated MAThrombin levels than healthy donors (2.3%) (p=0.005).

Conclusions:

  • Cardiac surgery patients exhibit heightened platelet reactivity and responsiveness to ADP, suggesting a potential link to increased ischemic event risk.
  • The findings indicate a higher prevalence of abnormal platelet reactivity in CABG patients, warranting further investigation into clinical implications.
Abstract

More Related Videos

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...